Primary Record
641569-94-0
- In stock
- 951 g
- Purity
- 99.5 %
- CAS
- 641569-94-0
Compound Identifiers & Properties
- CAS
- 641569-94-0
- PubChem CID
- 10402880
- SMILES
- CC1=C(C=C(C=C1)C(=O)O)NC2=NC=CC(=N2)C3=CN=CC=C3
- Canonical SMILES
- Cc1ccc(C(=O)O)cc1Nc1nccc(-c2cccnc2)n1
Names & Synonyms
- 641569-94-0
- 4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic acid
- null
- 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid
- TQ9WCS4PF0
- Nilotinib Impurity 2
- UNII-TQ9WCS4PF0
- Nilotinib Impurity 26
- MFCD11521324
- RefChem:99763
- Nilotinib EP Impurity D
- C17H14N4O2
- SCHEMBL533540
- BEN740
- SCHEMBL29707254
- CTK8C3847
- DTXSID90439380
- LDLZPHLSVKGFSC-UHFFFAOYSA-N
- BCP04528
- KS-00000I1D
- ANW-70664
- SBB063316
- ZINC38781402
- AKOS015888621
- AC-8510
- ACN-050713
- AN-6811
- FM32765
- MP-0103
- PS-7101
- SB57892
- VA10119
- CID10402880
- 4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzoic Acid
- 4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)benzoic acid
- AJ-96870
- AK-93453
- SC-93867
- SY107567
- AB0044025
- AB1004625
- TC-159409
- 4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzoic acid
- 4CH-008880
- A8804
- AM20090654
- CS-0009198
- FT-0655847
- ST24029168
- 4-Methyl-3-((4-(3-pyridyl)pyrimidin-2-yl)amino)benzoic acid
- Nilotinib hydrochloride monohydrate impurity D
- Nilotinib hydrochloride monohydrate impurity D [EP]
- Benzoic acid, 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-
- 1H-ISOINDOLE-5-METHANAMINE, 2,3-DIHYDRO-
- 4-(5-amino-6-hydroxy-2-benzoxazolyl)-benzoicacid
- 4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]benzoic acid
- 569M940
- F213194
- 4-Methyl-3-[[4- -2-pyrimidinyl]amino]benzoicacid
- Benzoic acid, 4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-
- I01-1255
- 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]b
- 4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoicacid
- 4-Methyl-3-4-(3-pyridinyl)-2-pyrimidinylaminobenzoic acid
- NILOTINIB HYDROCHLORIDE MONOHYDRATE IMPURITY D [EP IMPURITY]
- 3-{2-[(5-Carboxy-2-methylphenyl)amino]pyrimidin-4-yl}pyridine
- 4-methyl-3-(4-(pyridine-3-yl)pyrimidin-2-ylamino)benzoic acid
- 4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzoic acid
- 4-methyl-3-[(4-(3-pyridyl)pyrimidin-2-yl)amino]benzoic acid
- 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidiny]amino]benzoic acid
- 4-Methyl-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]benzoic Acid
- 4-Methyl-3[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid
- 2-[(5-Carboxy-2-methylphenyl)amino]-4-(pyridin-3-yl)pyrimidine
- 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzoic acid
- 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzoicacid
- 4-Methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoic Acid
- Benzoic acid,4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]
- Benzoic acid,4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-
- NILOTINIB HYDROCHLORIDE MONOHYDRATE IMPURITY D (EP IMPURITY)
- P20
- 629-968-8
- Benzoic acid, 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-; 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid; Nilotinib Hydrochloride Monohydrate Impurity D; Nilotinib Impurity D